Last reviewed · How we verify
18F-fluoromethylcholine
PET imaging agent for prostate cancer
PET imaging agent for prostate cancer Used for Prostate cancer.
At a glance
| Generic name | 18F-fluoromethylcholine |
|---|---|
| Also known as | fluorine-18 fluoromethylcholine, 18F-fluorocholine, 18F-choline, FCH |
| Sponsor | Queen's Medical Center |
| Drug class | Radioligand |
| Target | Choline kinase |
| Modality | Small molecule |
| Therapeutic area | Oncology |
| Phase | Phase 2 |
Mechanism of action
18F-fluoromethylcholine is a radioligand used for positron emission tomography (PET) imaging of prostate cancer.
Approved indications
- Prostate cancer
Common side effects
Key clinical trials
- Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors (PHASE2, PHASE3)
- Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas
- 99mTc Sestamibi SPECT/CT vs 18F Fluorocholine PET/CT (PHASE2, PHASE3)
- 18F-choline Positron-emission-tomography - Computed-tomography Compared to Conventional Imaging for Localizing Diseased Parathyroid Glands in Primary Hyperparathyroidism (NA)
- Prospective Comparison of 18F-choline PET/CT and 18F-FDG PET/CT in the Initial Work-up of Multiple Myeloma (PHASE3)
- Evaluation of Treatment Predictors Reflecting Beta-catenin Activation in Hepatocellular Carcinoma (PHASE2)
- High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins (NA)
- Clinical Application of the J-PET Scanner Prototype
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- 18F-fluoromethylcholine CI brief — competitive landscape report
- 18F-fluoromethylcholine updates RSS · CI watch RSS
- Queen's Medical Center portfolio CI